Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Latest European developments and new talent at Research Partnership

    March 19, 2024 | Careers, Growth, New hires 

    - PMLiVE

    Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its evolution into a global organization and forming part of Inizio Advisory. Her outstanding contributions to the company’s growth and expansion has led to her well-earned appointment to this new position. Angela will now spearhead the strategic growth of our European teams, ensuring our clients receive high quality insights and solutions to their business challenges.

    In addition, Grzegorz Stanczyk has joined Research Partnership as Operations Director, having previously worked at Hall and Partners. With a wealth of experience in operational strategy within the market research industry, Grzegorz will play a pivotal role in supporting our ad-hoc research teams and overseeing our Compliance and Commercial Affairs functions. His expertise in client and supplier contracting, as well as MSA negotiations, will help to enhance our operations.

    Helen Cox has joined the business as Senior Commercial Director. Helen is an accomplished insights professional with over 25 years’ experience, having led client engagement across healthcare clients in her most recent role at Ipsos, both in defining the overall strategy and leading client accounts. Helen brings a wealth of experience in strengthening client partnerships, understanding clients’ businesses, and bringing the very best expertise to every engagement, which will help to strengthen our commercial strategy at Research Partnership.

    CEO of Research Partnership, Gareth Phillips, commented “I am delighted to congratulate Angela on her new appointment and welcome Grzegorz and Helen to the team. Angela’s expertise will be instrumental in delivering enhanced value to our clients within the European sector. Grzegorz and Helen both bring a wealth of knowledge and fresh perspectives to our dynamic workforce, and I look forward to collaborating with them both as we strengthen our Operational and Commercial capabilities across our global teams.”

    Find out more and explore a range of resources at Research Partnership. 

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    RP Investigates – Q&A session: Living with Lupus

    In this 45-minute session, Head of Living With, Mariel Metcalfe spoke to Brenda, who was diagnosed with Lupus 12 years ago.

    Webcast: Demand Assessment

    Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.

    White paper: Are we prepared for the influx of CAR-Ts?

    Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

    New syndicated patient report – Living with Lupus US

    Living with Lupus US is a new syndicated patient report which offers valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs.

    Video: Emotion AI

    Artificial intelligence is revolutionising the way we conduct healthcare market research.

    Report: Mexico’s drug market access landscape shake-up: What does it mean for pharma?

    Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.

    Webcast: Virtual Q&A session – The future of digital health

    In this webcast, Senior Director, Richard Head and Director of The Medical Futurist, Dr. Bertalan Mesko host a live virtual Q&A discussion about the future of digital health.

    Research Partnership is on the rise

    Research Partnership ranks 12th in fastest growing UK market research agency league  tables

    What does the future hold for Light-chain Amyloidosis?

    Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...

    Webcast: Securing a future for telehealth with immersive market research insights

    Research Partnership investigate the current landscape, the challenges to adoption and the future for telehealth.